What is Afatinib Dimaleate 40 mg?
Afatinib Dimaleate 40 mg is a targeted cancer therapy medication used primarily for the treatment of Non-small cell lung cancer (NSCLC). It contains the active ingredient Afatinib Dimaleate, which acts as an irreversible inhibitor of the ErbB family of tyrosine kinases, including the epidermal growth factor receptor (EGFR). This mechanism interferes with cancer cell growth and proliferation.
Developed and manufactured by Boehringer Ingelheim India Pvt. Ltd., Afatinib Dimaleate 40 mg is carefully formulated to meet the medical needs of patients facing certain types of lung cancer. The medication is prescribed under strict medical supervision and is part of a comprehensive treatment strategy for advanced or metastatic NSCLC with specific genetic mutations.
In Malaysia, Afatinib Dimaleate 40 mg is recognized as an essential option in the fight against lung cancer, providing patients with a scientifically advanced treatment choice. The drug's design targets the cancer at a molecular level, allowing for a more precise approach compared to traditional chemotherapy.
Patients prescribed Afatinib Dimaleate 40 mg should follow their healthcare provider's instructions closely to ensure optimal effectiveness and minimize potential side effects.
Uses of Afatinib Dimaleate 40 mg
- Treatment of locally advanced or metastatic Non-small cell lung cancer
- Specifically effective for NSCLC cases with epidermal growth factor receptor (EGFR) mutations
- Used as a first-line therapy for EGFR mutation-positive NSCLC patients
- Helps in controlling the progression of lung tumors
How Afatinib Dimaleate 40 mg Works
Afatinib Dimaleate 40 mg works by irreversibly binding to and blocking the activity of the ErbB family of receptors including EGFR, HER2, and HER4. These receptors play a critical role in the signaling pathways that regulate cell division and survival. By inhibiting these receptors, Afatinib prevents the cancer cells from growing and multiplying.
The inhibition of EGFR-driven signaling pathways leads to reduced tumor growth, increased cancer cell death, and slowing down of cancer progression. The drug's irreversible binding means it forms a strong, lasting interaction with its target, offering effective suppression of tumor activity over time.
How to take Afatinib Dimaleate 40 mg
You should follow your healthcare provider's instructions carefully when taking Afatinib Dimaleate 40 mg. It is usually taken orally once daily, with or without food. Swallow the tablet whole with water, and do not crush or chew it.
Consistency in timing each day can help maintain steady levels of the medication in your bloodstream. Do not skip doses, and if you miss a dose, take it as soon as you remember unless it’s almost time for the next dose. Do not double the dose to catch up.
Regular monitoring by your doctor is essential to assess your response and manage any potential side effects effectively.
Benefits of Afatinib Dimaleate 40 mg
- Provides targeted therapy specifically for EGFR mutation-positive NSCLC
- Helps slow disease progression and improve quality of life
- Oral administration offers convenience compared to intravenous chemotherapy
- Can be used as a first-line treatment option for eligible patients
- Developed with precision to minimize damage to healthy cells
Dosage and Administration
The typical recommended dose of Afatinib Dimaleate 40 mg is one 40 mg tablet taken orally once daily. The dose may be adjusted by your physician based on your tolerance and treatment response.
Dose reductions to 30 mg or 20 mg may be necessary to manage side effects. Regular evaluation through clinical and laboratory tests will guide any changes in dosing.
Continue the medication for as long as your doctor advises or until disease progression or unacceptable toxicity occurs.
Who Should Use Afatinib Dimaleate 40 mg?
Afatinib Dimaleate 40 mg is intended for adult patients diagnosed with locally advanced or metastatic Non-small cell lung cancer who have tested positive for specific EGFR mutations. It is suitable for those who require targeted therapy as part of their cancer treatment.
Patients must be under medical supervision with appropriate diagnostic confirmation for effective and safe usage.
Who Should Avoid Afatinib Dimaleate 40 mg?
Individuals who have a known hypersensitivity to Afatinib or any of its components should avoid use. Also, those with severe liver impairment or certain pre-existing health conditions may be advised against taking this medication.
Pregnant or breastfeeding women should consult their healthcare provider before starting Afatinib Dimaleate 40 mg.
Side Effects of Afatinib Dimaleate 40 mg
- Diarrhea
- Rash
- Mouth sores
- Dry skin
- Nausea
- Vomiting
- Fatigue
- Loss of appetite
- Itching
- Dry eyes
- Cough
- Shortness of breath
Safety Advice
- Inform your doctor about all medications and supplements you are taking
- Report any severe or persistent side effects promptly
- Avoid exposure to sunlight and use sun protection to prevent skin reactions
- Stay hydrated and manage diarrhea with medical guidance
- Do not stop the medication without consulting your healthcare provider
- Attend all scheduled medical appointments for monitoring
Drug Interactions
- Other kinase inhibitors may increase side effects
- CYP3A4 inducers or inhibitors can affect Afatinib levels
- Drugs that affect stomach acidity may alter absorption
- Certain anticoagulants could have increased bleeding risk
- Always disclose full medication list to your doctor
Storage Instructions
Store Afatinib Dimaleate 40 mg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging to protect it from light. Ensure the medicine is stored out of reach of children and pets.
Where to buy Afatinib Dimaleate 40 mg in Malaysia?
Afatinib Dimaleate 40 mg is available through licensed pharmacies and hospitals in Malaysia. It is essential to obtain this medication from authorized sources to ensure safety and authenticity. Consultation with an oncologist or healthcare provider is required before purchase.
Frequently Asked Questions (FAQ)
What is the price of Afatinib Dimaleate 40 mg in Malaysia?
The price may vary based on the pharmacy and insurance coverage. It is advisable to check with local pharmacies or hospitals for exact pricing.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember unless it’s close to your next scheduled dose. Never double the dose to compensate for a missed one.
Where can I find Afatinib Dimaleate 40 mg for sale?
You can find Afatinib Dimaleate 40 mg in licensed pharmacies and healthcare facilities across Malaysia. Ensure you have a valid prescription.
Is Afatinib Dimaleate 40 mg available in Malaysia?
Yes, Afatinib Dimaleate 40 mg is available in Malaysia through authorized medical providers and pharmacies.
Can I take Afatinib Dimaleate 40 mg with other medications?
Some medications may interact with Afatinib. Always inform your doctor about all medicines you are taking to avoid adverse interactions.
Are there dietary restrictions while taking Afatinib Dimaleate 40 mg?
No specific dietary restrictions are required, but maintaining good hydration and a balanced diet is recommended.
How long does it take to see effects?
Treatment response varies; your doctor will monitor progress through regular tests and evaluations.
Conclusion
Afatinib Dimaleate 40 mg is a vital targeted therapy medication designed to treat Non-small cell lung cancer, especially in patients with EGFR mutations. Manufactured by Boehringer Ingelheim India Pvt. Ltd., it offers a modern approach to managing lung cancer by directly inhibiting cancer cell growth pathways. Patients in Malaysia seeking advanced treatment options may benefit from Afatinib, but usage should always be under strict medical guidance to ensure safety and optimal results.
Leave A Review